| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |